We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Data Bank for Eosinophilic Disorders

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00267475
First Posted: December 21, 2005
Last Update Posted: September 19, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Marc Rothenberg, Children's Hospital Medical Center, Cincinnati
December 15, 2005
December 21, 2005
September 19, 2013
May 2001
December 2012   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00267475 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Data Bank for Eosinophilic Disorders
Clinical and Immunological Evaluation of Eosinophil Associated Gastrointestinal Disorders (EGID)
The purpose of this study is to conduct a translational study in patients with primary eosinophil associated gastrointestinal disorders [EGID] (e.g. eosinophilic esophagitis eosinophilic gastritis, eosinophilic enteritis [EE], eosinophilic colitis, and eosinophilic gastroenteritis [EGE]) with the aim of developing a data bank containing pertinent patient demographic information, tissue samples, and DNA, which will facilitate research on the pathophysiology of inflammatory disorders and the development of a verified successful clinical treatment program.
Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients diagnosed with an eosinophilic disorder and patients without an eosinophilic disorder to serve as normal controls
  • Eosinophilic Esophagitis
  • Gastritis
  • Enteritis
  • Eosinophilic Colitis
  • Eosinophilic Gastroenteritis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
500
December 2012
December 2012   (Final data collection date for primary outcome measure)
Patients with an eosinophil associated gastrointestinal disorder (EGID), family members of patients with EGID, or normal controls.
Sexes Eligible for Study: All
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00267475
01-3-15
CSA1002171
Not Provided
Not Provided
Not Provided
Marc Rothenberg, Children's Hospital Medical Center, Cincinnati
Marc Rothenberg
Not Provided
Principal Investigator: Marc E. Rothenberg, M.D., Ph.D. Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center, Cincinnati
January 2013